Week 14 MDA Breakout Stocks - April 2022: Short-Term Picks To Give You An Edge
Summary
- Two sample Breakout Stocks for Week 14 with better than 10% short-term upside potential and a Dow stock pick.
- High frequency breakouts continue with peak gains in LOOP +13.7% and OUST +16.6%. 16 picks (30.7%) this year are up over 10% and as high as 142.3%.
- The streak of weekly picks gaining over 10% in less than a week of trading days increased to 206 out of 253 trading weeks (81.4%) not counting multiple gainers.
- The Momentum Gauge® signal turned negative midweek without an official buy signal ahead of week 14.
- The MDA breakout picks have beaten the S&P 500 for 5 consecutive years delivering a CAGR +49.8% and 726.0% compounding returns through 2021. 2021 returns were +70.5%.
- Looking for a helping hand in the market? Members of Value & Momentum Breakouts get exclusive ideas and guidance to navigate any climate. Learn More »
Bajak/E+ via Getty Images
Introduction
The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 7 years. This subset of the different portfolios I regularly analyze has now reached 250 weeks of public selections as part of this ongoing live forward-testing research. The frequency of 10%+ returns in a week is averaging over 4x the broad market averages over the past 5 years.
In 2017, the sample size began with 12 stocks, then 8 stocks in 2018, and at members' request since 2020, I now generate 4 selections each week. In addition 2 Dow 30 picks are provided, as well as a new active ETF portfolio that competes against a signal ETF model. Monthly Growth & Dividend MDA breakout stocks continue to beat the market each year as well. I offer 11 top models of short and long term value and momentum portfolios that have beaten the S&P 500 since my trading studies were made public:
The cumulative average breakout returns for 2022 is +47.55% not using the gauge signal. There has only been one full week of a positive signal in 2022 with the 2nd worst start to the stock market since the global financial crisis. Despite negative momentum conditions this year 16 picks (30.7%) are still up over 10% and as high as 142.3% (RES), +88.9% (TDW), +62.5% (IPI), and +52.6% (BPT) through the first quarter.
Additional background, measurements, and high frequency breakout records on the Weekly MDA Breakout model is here: Value And Momentum MDA Breakouts +70.5% In 52 Weeks: Final 2021 Year End Report Card
Returns from 21 Weeks of Positive Momentum Gauge signals in 2021
Last year there were only 21 positive trading weeks to achieve +70.5% returns and for 2022 we have only had one official positive weekly signal so far.
Momentum Gauge® trading signal: Negative conditions ahead of Week 14
Red weekly color indicates negative Momentum Gauge signals. MDA breakout selections tend to outperform when the signal is positive and negative values are below 40 level. This was an especially strong factor in 2021 showing cumulative returns below with and without the signal.
VMBreakouts.com
Historical Performance Measurements
The MDA Breakout minimal buy/hold returns are at +70.5% YTD when trading only in the positive weeks consistent with the positive Momentum Gauges® signals. Remarkably, the frequency streak of 10% gainers within a 4- or 5-day trading week continues at highly statistically significant levels above 80% not counting frequent multiple 10%+ gainers in a single week.
Longer term many of these selections join the V&M Multibagger list now up to 140 weekly picks with over 100%+ gains, 60 picks over 200%+, 22 picks over 500%+ and 8 picks with over 1000%+ gains since January 2019 such as:
- Intrepid Potash (IPI) +2,319.7%
- Enphase Energy (ENPH) +1,388.72%
- Celsius Holdings (CELH) +1,148.09%
- Trillium Therapeutics (TRIL) +1008.7%
More than 200 stocks have gained over 10% in a 5-day trading week since this MDA testing began in 2017. A frequency comparison chart is at the end of this article. Readers are cautioned that these are highly volatile stocks that may not be appropriate for achieving your long term investment goals: How to Achieve Optimal Asset Allocation
2022 Breakout Portfolio Returns
The Momentum Gauge® conditions are back to negative signals midweek with only one full week of positive conditions in 2022 with avg cumulative returns of +5.34% following the signals and avoiding the 2nd worst quarter to start the year since 2009.
The Breakout Picks are high volatility selections for high short-term gains, but with no selections below $2/share, under 100k average daily volume, or less than $100 million market cap. Prior returns are documented here:
2022 marks the worst start to the stock market since 2009 and the Momentum Gauge® MDA buy signals have turned positive into a second week after 17 consecutive weeks since Week 46 of last year. It is best to follow the signals and avoid momentum stocks until conditions turn positive.
Market Momentum Conditions
The Market Momentum Gauges® based on 7,500+ stocks continue positive this week at Negative 44 and Positive 82. However, the negative value is back above 40 warning level that ends the buy signal and the negative early test signal was triggered after 3 consecutive days of increasing negative levels.
The Weekly Momentum Gauges® have turned more positive into a second week for only the third time in 18 weeks since last November.
Two conditional signals that are very important to watch:
- Avoid/Minimize trading when the Negative score is higher than the Positive momentum score.
- Avoid/Minimize trading when the Negative score is above 40 on the gauge.
The Week 14 - 2022 Breakout Stocks for next week are:
The picks consist of 1 Energy, 1 Healthcare, 1 Financial and 1 Basic Material sector stock. These stocks are released to members in advance every Friday morning near the open and are up significantly. Prior selections may be doing well, but for research purposes I deliberately do not duplicate selections from the prior week. These selections are based on MDA characteristics from my research, including strong money flows, positive sentiment, and strong fundamentals -- but readers are cautioned to follow the Momentum Gauges® for the best results.
- Centennial Resource Development (CDEV) - Energy / Oil & Gas E&P
- Exact Sciences Corporation (EXAS) - Healthcare / Diagnostics
Centennial Resource Development - Energy / Oil & Gas E&P
FinViz.com
Price Target: $10.00/share (See my FAQ #20 on price targets)
Mar-30-22 07:41AM | Centennial Stock Jumps 41.6% YTD: More Room to Run? Zacks |
Mar-22-22 09:40AM | Are These Oils-Energy Stocks a Great Value Stocks Right Now? Zacks |
Mar-17-22 10:32AM | Matador Stock Rises 35.9% YTD: What's Driving It? Zacks |
Mar-15-22 10:40AM | Eni, BP to Form 50/50 JV by Combining Angola Businesses Zacks |
Mar-15-22 10:21AM | Centennial Jumps 27.1% Year to Date: More Room to Run? Zacks |
(Source: FinViz)
Centennial Resource Development, Inc., an independent oil and natural gas company, focuses on the development of unconventional oil and associated liquids-rich natural gas reserves in the United States. The company's assets primarily focus on the Delaware Basin, a sub-basin of the Permian Basin. Its properties consist of acreage blocks primarily in Reeves County in West Texas and Lea County in New Mexico. As of December 31, 2020, it leased or acquired approximately 81,657 net acres; and owned 1,472 net mineral acres in the Delaware Basin.
Source: Company resources
Exact Sciences Corporation - Healthcare / Diagnostics
FinViz.com
Price Target: $90.00/share (See my FAQ #20 on price targets)
Mar-31-22 08:54AM | Here's Why You Should Hold on to Exact Sciences Stock Zacks |
Mar-30-22 06:15PM | Exact Sciences Dips More Than Broader Markets: What You Should Know Zacks |
Mar-24-22 11:30AM | Exact Sciences Down 4.3% Since Last Earnings Report: Can It Rebound? Zacks |
Mar-15-22 06:15PM | Exact Sciences Stock Sinks As Market Gains: What You Should Know Zacks |
Mar-15-22 11:34AM | Exact Sciences Cologuard Sales Up but Costs Rise Zacks |
(Source: FinViz)
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer.
Source: Company resources
Top Dow 30 Stocks to Watch for Week 14
First, be sure to follow the Momentum Gauges® when applying the same MDA breakout model parameters to only 30 stocks on the Dow Index. Second, these selections are made without regard to market cap or the below-average volatility typical of mega-cap stocks that may produce good results relative to other Dow 30 stocks.
While I don't expect Dow stocks to outperform typical breakout stocks over the measured five-day breakout period, it may provide some strong additional basis for investors to judge future momentum performance for mega-cap stocks in the short- to medium-term. The most recent picks of weekly Dow selections in pairs for the last 5 weeks:
Symbol | Company | Current % return from selection Week |
(KO) | Coca Cola Company | +0.96% |
(JNJ) | Johnson & Johnson | +0.65% |
(HD) | Home Depot | -9.57% |
(CVX) | Chevron Corporation | +1.98% |
(TRV) | The Travelers Companies | +6.63% |
(CAT) | Caterpillar | +2.30% |
CVX | Chevron Corporation | +4.25% |
(WMT) | Walmart Inc. | +8.97% |
(AMGN) | Amgen, Inc. | +8.95% |
(MRK) | Merck & Co., Inc. | +11.55% |
If you are looking for a much broader selection of mega-cap breakout stocks beyond just 30 Dow stocks with more detailed analysis and strong returns, I would recommend the Growth & Dividend MDA Breakout picks.
These selections are significantly outperforming major Hedge Funds and all the hedge fund averages since inception. Consider the actively managed ARK Innovation fund down -28.60% YTD and Tiger Global hedge fund -34% and the Tiger Crossover hedge fund -21% YTD: Tech Rout Leads To Record 34% Loss At Tiger Global's Hedge Fund
These picks are released monthly for long term total return with strong returns that are leading the S&P 500 by +14.6% through 2022. The March selections are up +12.1% while all the major indices remain negative YTD. The 2-year returns of monthly portfolios are shown below:
VMBreakouts.com VMBreakouts.com
- The August MDA Breakout Growth & Dividend portfolio
- The September MDA Breakout Growth & Dividend portfolio
- The October MDA Breakout Growth & Dividend portfolio
- The November MDA Breakout Growth & Dividend portfolio
- The December MDA Breakout Growth & Dividend portfolio
- The January MDA Breakout Growth & Dividend portfolio
- The February MDA Breakout Growth & Dividend portfolio
- The March MDA Breakout Growth & Dividend portfolio
- The new April sample picks will be released soon.
The Dow pick for next week is:
The Coca-Cola Company
Coca-Cola continues again this week in strong breakout condition toward a retest of prior March highs ahead of earnings April 25th. Institutions are net buyers in the current quarter and consensus analyst price target is $67.4/share with net MFI inflows turning positive for the first time in March.
FinViz.com
Background on Momentum Breakout Stocks
As I have documented before from my research over the years, these MDA breakout picks were designed as high frequency gainers.
These documented high frequency gains in less than a week continue into 2020 at rates more than four times higher than the average stock market returns against comparable stocks with a minimum $2/share and $100 million market cap. The enhanced gains from further MDA research in 2020 are both larger and more frequent than in previous years in every category. ~ The 2020 MDA Breakout Report Card
The frequency percentages remain very similar to returns documented here on Seeking Alpha since 2017 and at rates that greatly exceed the gains of market returns by 2x and as much as 5x in the case of 5% gains.
VMBreakouts.com
(Value & Momentum Breakouts)
The 2021 and 2020 breakout percentages with 4 stocks selected each week.
MDA selections are restricted to stocks above $2/share, $100M market cap, and greater than 100k avg daily volume. Penny stocks well below these minimum levels have been shown to benefit greatly from the model but introduce much more risk and may be distorted by inflows from readers selecting the same micro-cap stocks.
Conclusion
These stocks continue the live forward-testing of the breakout selection algorithms from my doctoral research with continuous enhancements over prior years. These Weekly Breakout picks consist of the shortest duration picks of seven quantitative models I publish from top financial research that also include one-year buy/hold value stocks. Remember to follow the Momentum Gauges® in your investing decisions for the best results.
All the V&M portfolio types are beating the S&P 500 that is down -4.62% for 2022. The new active ETF portfolio is up +5.8% YTD and value portfolios of Piotroski-Graham and Growth & Dividend picks are up 10% through one of the worst quarters in stock market history.
The final 2021 returns for the different portfolio models from January of last year are shown below.
All the very best to you, stay safe and healthy and have a great week of trading!
JD Henning, PhD, MBA, CFE, CAMS
If you are looking for a great community to apply proven financial models with picks ranging from short term breakouts to long term value and forensic selections, join our 1,200+ outstanding members at Value & Momentum Breakouts
- Subscribe now and learn why members are hooked on the Momentum Gauge® signals!
- For the 5th year in a row 6 different portfolio models beat the S&P 500!
- The MDA Breakouts gained 70.5% with 5 year +47.98% CAGR
- Now into our 6th year, this rapidly growing service has consistently outperformed the S&P 500 every single year!
See what members are saying now - Click HERE
This article was written by
Welcome! I am a Finance PhD, MBA, investment adviser, fraud examiner and certified anti-money laundering specialist with more than 30 years trading and investing stocks and other securities. I'm the founder of Value & Momentum Breakouts.
***
I'm JD Henning, the founder of Value & Momentum Breakouts. I've spent decades capturing many of the best ways to consistently beat the markets. I've earned degrees researching markets, and even more importantly, I've spent the time myself as a trader and investor. I am one of those unusual multi-millionaire, PhD's in finance, former Coast Guard officer with a bunch of certifications ranging from anti-money laundering specialist, investment adviser, to fraud examiner... who genuinely enjoys helping others do well in the markets. I'm bringing the fruits of my experience and research to this service. I am highly accessible to members to answer questions and give guidance.
***
It's been quite the start of the year for investors. My guess is, after a decade of good times in the market, you’re here looking for some guidance in how to navigate these volatile markets and the uncertainty of the coronavirus and inflationary conditions. You’re in the right place. For the past 7 years I’ve made my trading systems public and helped thousands of my subscribers navigate and profit from every market downturn and breakout. Please be sure to read the reviews of my service from actual members!
***
Value & Momentum Breakouts doesn't stop with the Momentum Gauges® and the Bull/Bear ETF strategy. The service is designed for investors who appreciate having easy access to quick picks from many top quantitative financial models across different types of investing strategies. Portfolios and selections cover all types of investments:
***
Commodity and Volatility fund trading
Cryptocurrency chart analysis
Long term high-dividend growth stocks
Short term high-frequency breakout stocks
Forensic analysis value stocks
Value enhanced long term growth picks
ETF sector and bull/bear combination trades
Dow mega cap breakout picks
Sector and Index Momentum Gauges® for market timing
***
I share my expertise by generating frequent Value & Momentum Breakout stock portfolios from the different financial algorithms across peer-reviewed financial literature.
***
Try a 2-Week FREE trial and see all the value for yourself.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
I continue to follow the Market Momentum Gauge® and Sector Momentum Gauge® signals. I adjust my exposure ahead of weekends and holidays to minimize the risk from these high volatility 3x funds that may not be appropriate investments for your portfolio. Readers are highly encouraged to consider your own optimal asset allocation strategies to diversify risks and enhance returns.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.